72.6 F
New York
Thursday, October 1, 2020

Renewed Optimism is Surrounding Dare Bioscience Inc. (NASDAQ:DARE)

Must read

Waste Management Inc. (NYSE:WM) on the Path to Ruin

Waste Management Inc. (WM) shares are trading at lower $113.17 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

The Unprecedented Rise of Duke Realty Corporation (NYSE:DRE)

Duke Realty Corporation (DRE) shares are trading at lower $36.90 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

Investor Confidence is Rising for Sientra Inc. (NASDAQ:SIEN)

Sientra Inc. (SIEN) shares are trading at higher $3.40 and the avg recommendation for the stock is Strong Buy. To add more color to...

The Forecast Just Changed on Corsair Gaming Inc. (NASDAQ:CRSR)

Corsair Gaming Inc. (CRSR) shares are trading at higher $20.10. To add more color to this target, the company’s high over the last year...

The Dare Bioscience Inc. (DARE) shares are trading at higher $1.52 and the avg recommendation for the stock is Moderate Buy.

To add more color to this target, the company’s high over the last year is $2.22 and the low is $0.69. Over the last 52 weeks, DARE is down -31.53% while the S&P 500 is up 1.30%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, DARE reported a profit of $2000.0. Dare Bioscience Inc. also saw revenues increase to $4.25 million. In addition, DARE has free cash flow of -$6.6 million as of 03-2020. The company’s EBITDA came in at -$4.24 million which compares well with its peers.

DARE Return on Equity (ROE) is -616.40%, and its Return on Assets is -225.80%. All told, it is clear that, DARE needs to be on your watchlist.

Find out when DARE reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. DARE has a short ratio of 0.65 and outstanding shares of 23.80M.

Company Outlook

DARE has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 0.23 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -0.89. Dare Bioscience Inc. DARE also noted assets of $10.21 million at the end of the last quarter. Investors should also keep an eye on sector updates as DARE has historically followed its peers on positive news.

All told, Dare Bioscience Inc. DARE has strung together solid data and demonstrated underlying fundamentals. At its current valuation, DARE represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Dare Bioscience Inc. DARE is now commanding a market cap of 42.32M and a float of 23.49M. DARE is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of DARE stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in DARE, either long or short, and we have not been compensated for this article.

Latest article

Medallia Inc. (NYSE:MDLA) is Gaining Momentum on Earnings Catalyst

Medallia Inc. (MDLA) shares are trading at lower $27.42 and the avg recommendation for the stock is Strong Buy, while the current analyst price...

The Rejuvenation of Lam Research Corporation (NASDAQ:LRCX)

Lam Research Corporation (LRCX) shares are trading at lower $331.75 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

V.F. Corporation (NYSE:VFC) Recent Earnings Shows Major Promise

V.F. Corporation (VFC) shares are trading at higher $70.25 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

The Unprecedented Rise of Xilinx Inc. (NASDAQ:XLNX)

Xilinx Inc. (XLNX) shares are trading at higher $104.24 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

NXP Semiconductors N.V. (NASDAQ:NXPI) Finding Strong Support

NXP Semiconductors N.V. (NXPI) shares are trading at higher $124.81 and the avg recommendation for the stock is Moderate Buy, while the current analyst...